Original Research

Published on 08 Sep 2021

Development of Nomograms for Predicting Lymph Node Metastasis and Distant Metastasis in Newly Diagnosed T1-2 Non-Small Cell Lung Cancer: A Population-Based Analysis

in Thoracic Oncology

Yiming Qi
Shuangshuang Wu
Linghui Tao
Yunfu Shi
Wenjuan Yang
Lina Zhou
Bo Zhang
Jing Li

Frontiers in Oncology

doi 10.3389/fonc.2021.683282

2,989 views
10 citations

Clinical Trial

Published on 08 Sep 2021

A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer

in Thoracic Oncology

Chul Kim
Stephen V. Liu
Jennifer Crawford
Tisdrey Torres
Vincent Chen
Jillian Thompson
Ming Tan
Giuseppe Esposito
Deepa S. Subramaniam
Giuseppe Giaccone

Frontiers in Oncology

doi 10.3389/fonc.2021.728155

4,961 views
13 citations

Original Research

Published on 08 Sep 2021

Decreased IL-6 and NK Cells in Early-Stage Lung Adenocarcinoma Presenting as Ground-Glass Opacity

in Thoracic Oncology

Pengfei Zhang
Boxue He
Qidong Cai
Guangxu Tu
Xiong Peng
Zhenyu Zhao
Weilin Peng
Fenglei Yu
Min Wang
Yongguang Tao

Frontiers in Oncology

doi 10.3389/fonc.2021.705888

4,241 views
3 citations

Original Research

Published on 08 Sep 2021

Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients

in Thoracic Oncology

Naixin Liang
Lei Liu
Cheng Huang
Hongsheng Liu
Chao Guo
Ji Li
Weiwei Wang
Nan Li
Rui Lin
Tao Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.647512

5,037 views
7 citations

Systematic Review

Published on 07 Sep 2021

The Predictive Value of Clinical and Molecular Characteristics or Immunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

in Thoracic Oncology

Yangyang Xu
Qin Wang
Jingyuan Xie
Mo Chen
Hongbing Liu
Ping Zhan
Tangfeng Lv
Yong Song

Frontiers in Oncology

doi 10.3389/fonc.2021.732214

5,510 views
16 citations

Original Research

Published on 07 Sep 2021

Patterns of Failure in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

in Thoracic Oncology

Rong Chai
Yipengchen Yin
Xuwei Cai
Xiaolong Fu
Qin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.724722

3,136 views
4 citations

Correction

Published on 07 Sep 2021

Corrigendum: Prediction of EGFR Mutation Status Based on 18F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma

in Thoracic Oncology

Guotao Yin
Ziyang Wang
Yingchao Song
Xiaofeng Li
Yiwen Chen
Lei Zhu
Qian Su
Dong Dai
Wengui Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.747316

1,523 views
3 citations

Clinical Trial

Published on 06 Sep 2021

Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study

in Thoracic Oncology

Mark M. Awad
Yvan Le Bruchec
Brian Lu
Jason Ye
JulieAnn Miller
Patrick H. Lizotte
Megan E. Cavanaugh
Amanda J. Rode
Calin Dan Dumitru
Alexander Spira

Frontiers in Oncology

doi 10.3389/fonc.2021.696512

4,839 views
24 citations

Original Research

Published on 06 Sep 2021

DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma

in Thoracic Oncology

Didi Yuan
Zehong Wei
Yicheng Wang
Fang Cheng
Yujie Zeng
Li Yang
Shangyu Zhang
Jianbo Li
Renkuan Tang

Frontiers in Oncology

doi 10.3389/fonc.2021.734873

2,744 views
5 citations

Original Research

Published on 02 Sep 2021

EGFR Exon 18 Mutations in Advanced Non-Small Cell Lung Cancer: A Real-World Study on Diverse Treatment Patterns and Clinical Outcomes

in Thoracic Oncology

Haiyan Xu
Guangjian Yang
Weihua Li
Junling Li
Xuezhi Hao
Puyuan Xing
Yaning Yang
Yan Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.713483

18,414 views
11 citations

Original Research

Published on 01 Sep 2021

Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection

in Thoracic Oncology

Yu-Jia Shen
Li-Qiang Qian
Zheng-Ping Ding
Qing-Quan Luo
Heng Zhao
Wu-Yan Xia
Yuan-Yuan Fu
Wen Feng
Qin Zhang
Wen Yu

Frontiers in Oncology

doi 10.3389/fonc.2021.711206

3,160 views
21 citations

Mini Review

Published on 31 Aug 2021

BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer

in Thoracic Oncology

Clemence Demerlé
Laurent Gorvel
Daniel Olive

Frontiers in Oncology

doi 10.3389/fonc.2021.682007

7,383 views
38 citations

Original Research

Published on 30 Aug 2021

Pulmonary Neuroendocrine Neoplasms Overexpressing Epithelial-Mesenchymal Transition Mechanical Barriers Genes Lack Immune-Suppressive Response and Present an Increased Risk of Metastasis

in Thoracic Oncology

Tabatha Gutierrez Prieto
Camila Machado Baldavira
Juliana Machado-Rugolo
Cecília Farhat
Eloisa Helena Ribeiro Olivieri
Vanessa Karen de Sá
Eduardo Caetano Abilio da Silva
Marcelo Luiz Balancin
Alexandre Muxfeldt Ab´Saber
Teresa Yae Takagaki

Frontiers in Oncology

doi 10.3389/fonc.2021.645623

4,814 views
10 citations

Original Research

Published on 27 Aug 2021

Patterns of Recurrence and Survival Rate After Complete Resection of Pathological Stage N2 Small-Cell Lung Cancer

in Thoracic Oncology

Lian Yu
Jianlin Xu
Rong Qiao
Hua Zhong
Baohui Han
Runbo Zhong

Frontiers in Oncology

doi 10.3389/fonc.2021.675354

3,498 views
2 citations

Review

Published on 27 Aug 2021

Management of Large Cell Neuroendocrine Carcinoma

in Thoracic Oncology

Virginia Corbett
Susanne Arnold
Lowell Anthony
Aman Chauhan

Frontiers in Oncology

doi 10.3389/fonc.2021.653162

52,093 views
25 citations

Original Research

Published on 23 Aug 2021

Impact of Smoking History on Response to Immunotherapy in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Wenhua Zhao
Wei Jiang
Huilin Wang
Jianbo He
Cuiyun Su
Qitao Yu

Frontiers in Oncology

doi 10.3389/fonc.2021.703143

7,534 views
36 citations

Navigation group

Articles

Development of Nomograms for Predicting Lymph Node Metastasis and Distant Metastasis in Newly Diagnosed T1-2 Non-Small Cell Lung Cancer: A Population-Based Analysis

A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer

Decreased IL-6 and NK Cells in Early-Stage Lung Adenocarcinoma Presenting as Ground-Glass Opacity

Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients

The Predictive Value of Clinical and Molecular Characteristics or Immunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

Patterns of Failure in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

Corrigendum: Prediction of EGFR Mutation Status Based on 18F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma

Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study

DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma

EGFR Exon 18 Mutations in Advanced Non-Small Cell Lung Cancer: A Real-World Study on Diverse Treatment Patterns and Clinical Outcomes

Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection

BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer

Pulmonary Neuroendocrine Neoplasms Overexpressing Epithelial-Mesenchymal Transition Mechanical Barriers Genes Lack Immune-Suppressive Response and Present an Increased Risk of Metastasis

Patterns of Recurrence and Survival Rate After Complete Resection of Pathological Stage N2 Small-Cell Lung Cancer

Management of Large Cell Neuroendocrine Carcinoma

Impact of Smoking History on Response to Immunotherapy in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis